Global ASO-based Drug Market Growth (Status and Outlook) 2024-2030

July 2024 | 76 pages | ID: G092F37BF159EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases

The global ASO-based Drug market size is projected to grow from US$ 3938 million in 2024 to US$ 10620 million in 2030; it is expected to grow at a CAGR of 18.0% from 2024 to 2030.

LPI (LP Information)' newest research report, the “ASO-based Drug Industry Forecast” looks at past sales and reviews total world ASO-based Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected ASO-based Drug sales for 2023 through 2029. With ASO-based Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ASO-based Drug industry.

This Insight Report provides a comprehensive analysis of the global ASO-based Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on ASO-based Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ASO-based Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ASO-based Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ASO-based Drug.

United States market for ASO-based Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for ASO-based Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for ASO-based Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key ASO-based Drug players cover Ionis Pharmaceuticals, Biogen, Sobi, Nippon Shinyaku, Jazz Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of ASO-based Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Intrathecal Injection
• Intravenous Injections
• Other

Segmentation by Application:

• Neuromuscular Diseases
• hATTR
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Segmentation by Type:

• Intrathecal Injection
• Intravenous Injections
• Other

Segmentation by Application:

• Neuromuscular Diseases
• hATTR
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Ionis Pharmaceuticals
• Biogen
• Sobi
• Nippon Shinyaku
• Jazz Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global ASO-based Drug Market Size 2019-2030
  2.1.2 ASO-based Drug Market Size CAGR by Region (2019 VS 2023 VS 2030)
  2.1.3 World Current & Future Analysis for ASO-based Drug by Country/Region, 2019, 2023 & 2030
2.2 ASO-based Drug Segment by Type
  2.2.1 Intrathecal Injection
  2.2.2 Intravenous Injections
  2.2.3 Other
2.3 ASO-based Drug Market Size by Type
  2.3.1 ASO-based Drug Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global ASO-based Drug Market Size Market Share by Type (2019-2024)
2.4 ASO-based Drug Segment by Application
  2.4.1 Neuromuscular Diseases
  2.4.2 hATTR
  2.4.3 Other
2.5 ASO-based Drug Market Size by Application
  2.5.1 ASO-based Drug Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global ASO-based Drug Market Size Market Share by Application (2019-2024)

3 ASO-BASED DRUG MARKET SIZE BY PLAYER

3.1 ASO-based Drug Market Size Market Share by Player
  3.1.1 Global ASO-based Drug Revenue by Player (2019-2024)
  3.1.2 Global ASO-based Drug Revenue Market Share by Player (2019-2024)
3.2 Global ASO-based Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ASO-BASED DRUG BY REGION

4.1 ASO-based Drug Market Size by Region (2019-2024)
4.2 Global ASO-based Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas ASO-based Drug Market Size Growth (2019-2024)
4.4 APAC ASO-based Drug Market Size Growth (2019-2024)
4.5 Europe ASO-based Drug Market Size Growth (2019-2024)
4.6 Middle East & Africa ASO-based Drug Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas ASO-based Drug Market Size by Country (2019-2024)
5.2 Americas ASO-based Drug Market Size by Type (2019-2024)
5.3 Americas ASO-based Drug Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC ASO-based Drug Market Size by Region (2019-2024)
6.2 APAC ASO-based Drug Market Size by Type (2019-2024)
6.3 APAC ASO-based Drug Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe ASO-based Drug Market Size by Country (2019-2024)
7.2 Europe ASO-based Drug Market Size by Type (2019-2024)
7.3 Europe ASO-based Drug Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa ASO-based Drug by Region (2019-2024)
8.2 Middle East & Africa ASO-based Drug Market Size by Type (2019-2024)
8.3 Middle East & Africa ASO-based Drug Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ASO-BASED DRUG MARKET FORECAST

10.1 Global ASO-based Drug Forecast by Region (2025-2030)
  10.1.1 Global ASO-based Drug Forecast by Region (2025-2030)
  10.1.2 Americas ASO-based Drug Forecast
  10.1.3 APAC ASO-based Drug Forecast
  10.1.4 Europe ASO-based Drug Forecast
  10.1.5 Middle East & Africa ASO-based Drug Forecast
10.2 Americas ASO-based Drug Forecast by Country (2025-2030)
  10.2.1 United States Market ASO-based Drug Forecast
  10.2.2 Canada Market ASO-based Drug Forecast
  10.2.3 Mexico Market ASO-based Drug Forecast
  10.2.4 Brazil Market ASO-based Drug Forecast
10.3 APAC ASO-based Drug Forecast by Region (2025-2030)
  10.3.1 China ASO-based Drug Market Forecast
  10.3.2 Japan Market ASO-based Drug Forecast
  10.3.3 Korea Market ASO-based Drug Forecast
  10.3.4 Southeast Asia Market ASO-based Drug Forecast
  10.3.5 India Market ASO-based Drug Forecast
  10.3.6 Australia Market ASO-based Drug Forecast
10.4 Europe ASO-based Drug Forecast by Country (2025-2030)
  10.4.1 Germany Market ASO-based Drug Forecast
  10.4.2 France Market ASO-based Drug Forecast
  10.4.3 UK Market ASO-based Drug Forecast
  10.4.4 Italy Market ASO-based Drug Forecast
  10.4.5 Russia Market ASO-based Drug Forecast
10.5 Middle East & Africa ASO-based Drug Forecast by Region (2025-2030)
  10.5.1 Egypt Market ASO-based Drug Forecast
  10.5.2 South Africa Market ASO-based Drug Forecast
  10.5.3 Israel Market ASO-based Drug Forecast
  10.5.4 Turkey Market ASO-based Drug Forecast
10.6 Global ASO-based Drug Forecast by Type (2025-2030)
10.7 Global ASO-based Drug Forecast by Application (2025-2030)
  10.7.1 GCC Countries Market ASO-based Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Ionis Pharmaceuticals
  11.1.1 Ionis Pharmaceuticals Company Information
  11.1.2 Ionis Pharmaceuticals ASO-based Drug Product Offered
  11.1.3 Ionis Pharmaceuticals ASO-based Drug Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Ionis Pharmaceuticals Main Business Overview
  11.1.5 Ionis Pharmaceuticals Latest Developments
11.2 Biogen
  11.2.1 Biogen Company Information
  11.2.2 Biogen ASO-based Drug Product Offered
  11.2.3 Biogen ASO-based Drug Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Biogen Main Business Overview
  11.2.5 Biogen Latest Developments
11.3 Sobi
  11.3.1 Sobi Company Information
  11.3.2 Sobi ASO-based Drug Product Offered
  11.3.3 Sobi ASO-based Drug Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Sobi Main Business Overview
  11.3.5 Sobi Latest Developments
11.4 Nippon Shinyaku
  11.4.1 Nippon Shinyaku Company Information
  11.4.2 Nippon Shinyaku ASO-based Drug Product Offered
  11.4.3 Nippon Shinyaku ASO-based Drug Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Nippon Shinyaku Main Business Overview
  11.4.5 Nippon Shinyaku Latest Developments
11.5 Jazz Pharmaceuticals
  11.5.1 Jazz Pharmaceuticals Company Information
  11.5.2 Jazz Pharmaceuticals ASO-based Drug Product Offered
  11.5.3 Jazz Pharmaceuticals ASO-based Drug Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Jazz Pharmaceuticals Main Business Overview
  11.5.5 Jazz Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. ASO-based Drug Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. ASO-based Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Intrathecal Injection
Table 4. Major Players of Intravenous Injections
Table 5. Major Players of Other
Table 6. ASO-based Drug Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global ASO-based Drug Market Size by Type (2019-2024) & ($ millions)
Table 8. Global ASO-based Drug Market Size Market Share by Type (2019-2024)
Table 9. ASO-based Drug Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global ASO-based Drug Market Size by Application (2019-2024) & ($ millions)
Table 11. Global ASO-based Drug Market Size Market Share by Application (2019-2024)
Table 12. Global ASO-based Drug Revenue by Player (2019-2024) & ($ millions)
Table 13. Global ASO-based Drug Revenue Market Share by Player (2019-2024)
Table 14. ASO-based Drug Key Players Head office and Products Offered
Table 15. ASO-based Drug Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global ASO-based Drug Market Size by Region (2019-2024) & ($ millions)
Table 19. Global ASO-based Drug Market Size Market Share by Region (2019-2024)
Table 20. Global ASO-based Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global ASO-based Drug Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas ASO-based Drug Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas ASO-based Drug Market Size Market Share by Country (2019-2024)
Table 24. Americas ASO-based Drug Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas ASO-based Drug Market Size Market Share by Type (2019-2024)
Table 26. Americas ASO-based Drug Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas ASO-based Drug Market Size Market Share by Application (2019-2024)
Table 28. APAC ASO-based Drug Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC ASO-based Drug Market Size Market Share by Region (2019-2024)
Table 30. APAC ASO-based Drug Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC ASO-based Drug Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe ASO-based Drug Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe ASO-based Drug Market Size Market Share by Country (2019-2024)
Table 34. Europe ASO-based Drug Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe ASO-based Drug Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa ASO-based Drug Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa ASO-based Drug Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa ASO-based Drug Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of ASO-based Drug
Table 40. Key Market Challenges & Risks of ASO-based Drug
Table 41. Key Industry Trends of ASO-based Drug
Table 42. Global ASO-based Drug Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global ASO-based Drug Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global ASO-based Drug Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global ASO-based Drug Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Ionis Pharmaceuticals Details, Company Type, ASO-based Drug Area Served and Its Competitors
Table 47. Ionis Pharmaceuticals ASO-based Drug Product Offered
Table 48. Ionis Pharmaceuticals ASO-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Ionis Pharmaceuticals Main Business
Table 50. Ionis Pharmaceuticals Latest Developments
Table 51. Biogen Details, Company Type, ASO-based Drug Area Served and Its Competitors
Table 52. Biogen ASO-based Drug Product Offered
Table 53. Biogen ASO-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Sobi Details, Company Type, ASO-based Drug Area Served and Its Competitors
Table 57. Sobi ASO-based Drug Product Offered
Table 58. Sobi ASO-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Sobi Main Business
Table 60. Sobi Latest Developments
Table 61. Nippon Shinyaku Details, Company Type, ASO-based Drug Area Served and Its Competitors
Table 62. Nippon Shinyaku ASO-based Drug Product Offered
Table 63. Nippon Shinyaku ASO-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Nippon Shinyaku Main Business
Table 65. Nippon Shinyaku Latest Developments
Table 66. Jazz Pharmaceuticals Details, Company Type, ASO-based Drug Area Served and Its Competitors
Table 67. Jazz Pharmaceuticals ASO-based Drug Product Offered
Table 68. Jazz Pharmaceuticals ASO-based Drug Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Jazz Pharmaceuticals Main Business
Table 70. Jazz Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. ASO-based Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ASO-based Drug Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. ASO-based Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. ASO-based Drug Sales Market Share by Country/Region (2023)
Figure 8. ASO-based Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global ASO-based Drug Market Size Market Share by Type in 2023
Figure 10. ASO-based Drug in Neuromuscular Diseases
Figure 11. Global ASO-based Drug Market: Neuromuscular Diseases (2019-2024) & ($ millions)
Figure 12. ASO-based Drug in hATTR
Figure 13. Global ASO-based Drug Market: hATTR (2019-2024) & ($ millions)
Figure 14. ASO-based Drug in Other
Figure 15. Global ASO-based Drug Market: Other (2019-2024) & ($ millions)
Figure 16. Global ASO-based Drug Market Size Market Share by Application in 2023
Figure 17. Global ASO-based Drug Revenue Market Share by Player in 2023
Figure 18. Global ASO-based Drug Market Size Market Share by Region (2019-2024)
Figure 19. Americas ASO-based Drug Market Size 2019-2024 ($ millions)
Figure 20. APAC ASO-based Drug Market Size 2019-2024 ($ millions)
Figure 21. Europe ASO-based Drug Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa ASO-based Drug Market Size 2019-2024 ($ millions)
Figure 23. Americas ASO-based Drug Value Market Share by Country in 2023
Figure 24. United States ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC ASO-based Drug Market Size Market Share by Region in 2023
Figure 29. APAC ASO-based Drug Market Size Market Share by Type (2019-2024)
Figure 30. APAC ASO-based Drug Market Size Market Share by Application (2019-2024)
Figure 31. China ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 35. India ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe ASO-based Drug Market Size Market Share by Country in 2023
Figure 38. Europe ASO-based Drug Market Size Market Share by Type (2019-2024)
Figure 39. Europe ASO-based Drug Market Size Market Share by Application (2019-2024)
Figure 40. Germany ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 41. France ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 42. UK ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa ASO-based Drug Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa ASO-based Drug Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa ASO-based Drug Market Size Market Share by Application (2019-2024)
Figure 48. Egypt ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries ASO-based Drug Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 54. APAC ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 55. Europe ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 57. United States ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 58. Canada ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 59. Mexico ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 60. Brazil ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 61. China ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 62. Japan ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 63. Korea ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 65. India ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 66. Australia ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 67. Germany ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 68. France ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 69. UK ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 70. Italy ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 71. Russia ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 72. Egypt ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 73. South Africa ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 74. Israel ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 75. Turkey ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries ASO-based Drug Market Size 2025-2030 ($ millions)
Figure 77. Global ASO-based Drug Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global ASO-based Drug Market Size Market Share Forecast by Application (2025-2030)